WO2004101796A1 - 改良された形質転換体およびそれを用いたポリエステルの製造方法 - Google Patents
改良された形質転換体およびそれを用いたポリエステルの製造方法 Download PDFInfo
- Publication number
- WO2004101796A1 WO2004101796A1 PCT/JP2004/006542 JP2004006542W WO2004101796A1 WO 2004101796 A1 WO2004101796 A1 WO 2004101796A1 JP 2004006542 W JP2004006542 W JP 2004006542W WO 2004101796 A1 WO2004101796 A1 WO 2004101796A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- genus
- yeast
- polyester
- ser
- Prior art date
Links
- 229920000728 polyester Polymers 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title abstract description 44
- 230000008569 process Effects 0.000 title abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 77
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 63
- 230000014509 gene expression Effects 0.000 claims abstract description 35
- 241000607534 Aeromonas Species 0.000 claims abstract description 14
- 239000002253 acid Substances 0.000 claims abstract description 8
- 108010010718 poly(3-hydroxyalkanoic acid) synthase Proteins 0.000 claims description 59
- 150000001413 amino acids Chemical class 0.000 claims description 35
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 claims description 33
- 238000004519 manufacturing process Methods 0.000 claims description 27
- 210000002824 peroxisome Anatomy 0.000 claims description 20
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 18
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 238000006467 substitution reaction Methods 0.000 claims description 10
- 230000002068 genetic effect Effects 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 8
- HPMGFDVTYHWBAG-UHFFFAOYSA-N 3-hydroxyhexanoic acid Chemical compound CCCC(O)CC(O)=O HPMGFDVTYHWBAG-UHFFFAOYSA-N 0.000 claims description 6
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
- 101710096706 Poly(3-hydroxyalkanoate) polymerase Proteins 0.000 claims 2
- 101710159749 Poly(3-hydroxyalkanoate) polymerase subunit PhaC Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000035772 mutation Effects 0.000 abstract description 22
- 150000007513 acids Chemical class 0.000 abstract description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 55
- 239000013612 plasmid Substances 0.000 description 32
- 229920000642 polymer Polymers 0.000 description 32
- 235000001014 amino acid Nutrition 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 22
- 241000222128 Candida maltosa Species 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 14
- 229910052799 carbon Inorganic materials 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 11
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 238000011144 upstream manufacturing Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 241000607516 Aeromonas caviae Species 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 235000009582 asparagine Nutrition 0.000 description 4
- 229960001230 asparagine Drugs 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 101150000418 ALK1 gene Proteins 0.000 description 3
- 241000722885 Brettanomyces Species 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 241000252867 Cupriavidus metallidurans Species 0.000 description 3
- 241001465321 Eremothecium Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 241000235003 Saccharomycopsis Species 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 108700026220 vif Genes Proteins 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 2
- 241001508809 Ambrosiozyma Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241001508785 Arxiozyma Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000222178 Candida tropicalis Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001508811 Clavispora Species 0.000 description 2
- 230000009946 DNA mutation Effects 0.000 description 2
- 241000235035 Debaryomyces Species 0.000 description 2
- 241000159512 Geotrichum Species 0.000 description 2
- 241001149669 Hanseniaspora Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- 241001489120 Kondoa Species 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 241001149698 Lipomyces Species 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 101100490437 Mus musculus Acvrl1 gene Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 241000193596 Nadsonia Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000235652 Pachysolen Species 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 241001542817 Phaffia Species 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000223252 Rhodotorula Species 0.000 description 2
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000040567 Sterigmatosporidium Species 0.000 description 2
- 241000122237 Symbiotaphrina Species 0.000 description 2
- 241001523623 Sympodiomycopsis Species 0.000 description 2
- 241000400381 Trichosporiella Species 0.000 description 2
- 241000223230 Trichosporon Species 0.000 description 2
- 241000311098 Yamadazyma Species 0.000 description 2
- 241000235013 Yarrowia Species 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- -1 ester salts Chemical class 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 150000004688 heptahydrates Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- 150000004685 tetrahydrates Chemical class 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- 102100034111 Activin receptor type-1 Human genes 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 101100277337 Arabidopsis thaliana DDM1 gene Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000235114 Bensingtonia Species 0.000 description 1
- 241000178289 Botryozyma Species 0.000 description 1
- 241000235172 Bullera Species 0.000 description 1
- 241000033328 Bulleromyces Species 0.000 description 1
- 101100324465 Caenorhabditis elegans arr-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241001508787 Citeromyces Species 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 241000222039 Cystofilobasidium Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 241001123630 Dipodascopsis Species 0.000 description 1
- 241001123635 Dipodascus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000222042 Erythrobasidium Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000222840 Fellomyces Species 0.000 description 1
- 241001123633 Galactomyces Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 241001236629 Holtermannia Species 0.000 description 1
- 101000799140 Homo sapiens Activin receptor type-1 Proteins 0.000 description 1
- 241000376403 Hyphopichia Species 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 241001304304 Kuraishia Species 0.000 description 1
- 241000222661 Kurtzmanomyces Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 101150022713 LAC4 gene Proteins 0.000 description 1
- 241000287456 Laniidae Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000221479 Leucosporidium Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241001508815 Lodderomyces Species 0.000 description 1
- 108010061951 Methemoglobin Proteins 0.000 description 1
- 241001123674 Metschnikowia Species 0.000 description 1
- 241001149967 Mrakia Species 0.000 description 1
- 241000529863 Myxozyma Species 0.000 description 1
- 241001099335 Nakazawaea Species 0.000 description 1
- 241001112159 Ogataea Species 0.000 description 1
- 241000159576 Oosporidium Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101100043657 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CHA1 gene Proteins 0.000 description 1
- 241001489223 Saccharomycodes Species 0.000 description 1
- 241000222838 Saitoella Species 0.000 description 1
- 241001514651 Sakaguchia Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000311088 Schwanniomyces Species 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 241000193640 Sporopachydermia Species 0.000 description 1
- 241000222665 Sterigmatomyces Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000159597 Sympodiomyces Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000235006 Torulaspora Species 0.000 description 1
- 241000222671 Tsuchiyaea Species 0.000 description 1
- 241000145580 Udeniomyces Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000193620 Wickerhamia Species 0.000 description 1
- 241000193624 Wickerhamiella Species 0.000 description 1
- 241000235152 Williopsis Species 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- 241000222676 Zygoascus Species 0.000 description 1
- 241000235017 Zygosaccharomyces Species 0.000 description 1
- 241000685534 Zygowilliopsis Species 0.000 description 1
- 241000193645 Zygozyma Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 229920000229 biodegradable polyester Polymers 0.000 description 1
- 239000004622 biodegradable polyester Substances 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000021523 carboxylation Effects 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical group [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- XQGPKZUNMMFTAL-UHFFFAOYSA-L dipotassium;hydrogen phosphate;trihydrate Chemical compound O.O.O.[K+].[K+].OP([O-])([O-])=O XQGPKZUNMMFTAL-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 108010027322 single cell proteins Proteins 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
- C12P7/625—Polyesters of hydroxy carboxylic acids
Definitions
- the present invention relates to an improved transformant and a method for producing a polyester using the same.
- the present invention relates to a gene required for enzymatically synthesizing a copolymerized polyester, a microorganism for fermenting and synthesizing a polyester using the gene, and a method for producing a polyester using the microorganism.
- PHA polyhydroxyalkanoic acid
- a typical example is poly-3-hydroxybutyric acid (hereinafter abbreviated as P (3HB)), which is a homopolymer of 3-hydroxybutyric acid (hereinafter abbreviated as 3HB).
- P (3HB) is a thermoplastic polymer, which has been attracting attention as an environmentally friendly plastic because it is biodegradable in the natural environment.
- P (3HB) has high crystallinity and is hard and brittle, so its practical application is limited. For this reason, research aimed at improving this property has been made.
- P (3HB-CO-3HH) 3HB and 3-hydroxyhexanoic acid
- 3HH 3-hydroxyhexanoic acid
- Patent Documents 3 and 4 The process for producing P (3HB-co-3HH) in these patent documents uses oleic acid using Aeromonas caviae isolated from soil. It was produced by fermentation from fats and oils such as fatty oils such as pure oil. Also, studies on the properties of P (3H B—co—3HH) have been made (see Non-Patent Document 2). In this report, A.
- caviae is cultivated using fatty acids having 12 or more carbon atoms as the sole carbon source, and 3HH fermentatively produces 11 to 19 mol% of P (3HB_co_3HH).
- P (3HB_co_3HH) increases in mole fraction of 3HH, P (3HB) gradually becomes more flexible from hard and brittle to P (3HB-co_3HV). It was decided.
- the cell production was 4 gZL, the polymer content was 30%, and the polymer productivity was low. Therefore, a method for obtaining higher productivity for practical use was searched.
- a PHA synthase gene has been cloned from A. caviae producing P (3HB_co_3HH) (see Patent Document 5 and Non-Patent Document 3).
- This gene was cultured in a transgenic strain transfected into Ralstonia eutropha (formerly Alcaligenes eutrophus) using vegetable oil as a carbon source, resulting in a cell content of 4 g and a polymer content of 80%. (See Non-Patent Document 4).
- Also disclosed is a method for producing P (3HB-co-3HH) using bacteria such as Escherichia coli and plants as hosts, and its productivity is described (see Patent Document 6).
- the polymer P (3HB-CO-3HH) has a wide range of physical properties from a hard polymer to a soft polymer by changing the mole fraction of 3HH. It can be expected to be applied to a wide range of fields, from those that require flexibility, such as thread and film. However, the productivity of P (3HB-co_3HH) is still low with the above-mentioned manufacturing method, and it is still insufficient as a production method for the practical use of P (3HB-co-3HH). I have to know.
- P. (3HB-co_3HH) synthase derived from A. caviae was modified by Evolutional engineering by Yoshise et al. And transfected into Escherichia coli, whereby P (3HB- A method for producing Escherichia coli that highly accumulates CO-3HH) was disclosed (see Non-Patent Document 5).
- E2-50 strain and T3-11 strain were obtained as strains having improved specific activity of P (3HB_co_3HH) synthase.
- the 149th amino acid asparagine of P (3HB-CO-3HH) synthase was replaced with serine, and in the T3-11 strain, 171st asp.
- Yeasts are known to grow quickly and have high cell productivity.
- yeast belonging to the genus Candida has been attracting attention as a single cell protein in the past, ⁇ Production of feed-use cells as a carbon source has been studied.
- a host vector system of the genus-(Candida) has been developed, and substance production using gene recombination technology has been reported (see Non-Patent Document 10).
- the productivity of para-amylase using Candida utilis as a host is as high as about 12.3 g / L, and the genus Candida, which has such a high ability to produce substances, is used for polymer production.
- the separation of cells from the culture solution is easier than that of bacteria, the extraction and purification steps of the polymer can be further simplified.
- P (3HB-CO-3HH) having excellent physical properties using yeasts of the genus Candida has been developed. It is necessary to further improve in terms of polymer productivity.
- One method for improving the amount of polymer produced per cell is to increase the amount of polymer synthase in the cell.
- Methods for increasing the amount of polymer synthase in the bacterium include a method using a strong promoter, a method using a plasmid with a high copy number, and a method of introducing a large number of enzyme expression units into a plasmid or chromosome.
- Non-Patent Documents 11 and 12 Since the molecular weight of a polymer greatly affects the properties of a biodegradable polymer, it has been desired to develop a method for improving productivity without causing a decrease in molecular weight.
- Patent Document 1 JP-A-57-150393
- Patent Document 2 JP-A-59-220192
- Patent Document 3 JP-A-5-93049
- Patent Document 4 JP-A-7-265065
- Patent Document 5 JP-A-10-108682
- Patent Document 6 WO 00/43525 pamphlet
- Patent Document 7 International Publication No. 01/88144 pamphlet
- Non-Patent Document 1 M. Lemoigne, Ann. Inst. Pasteur, 39, 144 (1925)
- Non-Patent Document 2 Y. Doi, S. Kitamura, H. Abe, Macromolecules 28, 4822-4 823 (1995)
- Patent Document 3 T. Fukui, Y. Doi, J. Bacteriol, vol. 179, No. 15, 4821-4830 (1997)
- Non-Patent Document 4 T. Fukui et al. Appl. Microbiol. Biotechnol. 49, 333 (1998)
- Non-Patent Document 5 T. Kichise et al. Appl. Environ. Microbiol. 68, 2411-2419 (2002)
- Non-Patent Document 6 Amara AA. Et al. Appl. Microbiol. Biotechnol. 59, 477-482 (2002)
- Non-Patent Document 7 Microbiology, vol. 142, ppl 169—1180 (1996)
- Non-Patent Document 8 Poirier Y. et al. Appl. Microbiol. Biotechnol. 67, 5254-5260
- Non-Patent Document 9 Poirier Y. et al. FEMS Microbiology Lett., Vol. 207, pp97_102 (2002)
- Patent Literature 10 Danigaku and Biology vol. 38, No. 9, 614 (2000)
- Non-patent literature l l Sim S. J. et al. Nature Biotechnology, vol. 15, pp63_67 (1997)
- Non-patent Document 12 Gerngross T.U., Martin D.P., Proc. Natl. Acad. Sci. USA, vol. 92, pp6279-6283 (1995)
- the present invention provides a PHA synthase mutant gene that can be functionally and efficiently expressed in yeast, a transformant obtained by transforming a gene expression cassette comprising the mutant gene into yeast, and the obtained character.
- An object of the present invention is to provide a method for producing a polyester such as P (3HB-CO-3HH) having biodegradability and excellent physical properties by culturing the transformant.
- the present inventors have prepared genes encoding the amino acid sequences of mutants in which a specific mutation has been introduced into the amino acid sequence of the PHA synthase derived from Aeromonas serrata, and these genes have been prepared.
- Each of which has a promoter A gene expression cassette is prepared by linking a minator, and then the present gene expression set is introduced into yeast to produce a transformant, and by culturing the transformant, extremely high productivity can be obtained from the culture. Found that polyester can be produced in a promising way.
- the present invention relates to the use of a gene of a PHA synthase mutant derived from Aeromonas serrata in yeast.
- a PHA synthase mutation obtained by performing at least one of the following amino acid substitutions (a) to (h) on a PHA synthase derived from Aeromonas serrata consisting of the amino acid sequence represented by SEQ ID NO: 1
- the present invention relates to a gene expression cassette comprising a PHA synthase mutant gene encoding a body, and a promoter and a terminator that function in yeast.
- the present invention also relates to a gene obtained by adding a DNA encoding a peroxisome orientation signal to a PHA synthase mutant gene encoding the above PHA synthase mutant.
- the gene comprises the amino acid sequence represented by SEQ ID NO: 2 or SEQ ID NO: 3; more preferably, the nucleotide sequence of the DNA encoding the peroxisome orientation signal is SEQ ID NO: 4. Or the gene as set forth in SEQ ID NO: 5.
- the above-mentioned gene which is converted to at least one of the genetic code CTG of a gene coding for a PHA synthase derived from Aeromonas radians TTA, TTG, CTT, CTC or CTA About.
- the present invention provides the above-mentioned gene, a promoter and a terminator capable of functioning in yeast.
- the present invention is particularly characterized in that one or more gene expression cassettes are introduced into yeast.
- a transformant to be characterized preferably, the above transformant, wherein the yeast is Candida maltosa.
- the present invention provides a method for collecting polyester from a culture obtained by culturing the transformant of form 1
- the polyester is a copolymer of 3_hydroxybutyric acid represented by the following formula (1) and 3-hydroxyhexanoic acid represented by the following formula (2):
- the present invention relates to a method for producing the above polyester which is a copolymerized polyester obtained by polymerization.
- a PHA synthase mutation obtained by performing at least one of the following amino acid substitutions (a) to (h) on the amino acid sequence of the PHA synthase derived from Aeromonas The body is used as a useful variant.
- Amin_149 means asparagine at position 149 in the amino acid sequence
- amino acid substitution in (a) means conversion of asparagine at position 149 to serine.
- Examples of the method for obtaining the above mutant include the following methods. There are various methods for obtaining a mutant having improved properties such as enzyme activity 'substrate specificity' and thermostability by modifying the amino acid sequence of a polyester synthase derived from a bacterium such as Aeromonas caviae. Although known, in particular, a molecular evolution engineering technique (Japanese Patent Application Laid-Open No. 2002-199890) is highly useful because a desired mutant can be quickly obtained. Further, it is also possible to specify a useful amino acid mutation on the basis of the three-dimensional structure of the enzyme or a predicted three-dimensional structure on a computer, for example, using the program Shrike (Japanese Patent Application Laid-Open No. 2001-184831). .
- amino acid substitutions (a) to (h) A mutant obtained by performing two or more of the above is also preferably used.
- the gene encoding the mutant obtained by the method described in (1) above includes a sequence number A PHA synthase gene derived from Aeromonas serrata consisting of the amino acid sequence represented by No. 1 and having a DNA mutation corresponding to the amino acid substitution described in (1) above may be mentioned. Further, a PHA synthase gene adapted to yeast into which a DNA mutation corresponding to the amino acid substitution described in (1) above has been introduced is preferable.
- the PHA synthase gene adapted to yeast is not particularly limited, and is, for example, a gene encoding the same amino acid sequence in Candida maltosa as the PHA synthase gene derived from Aeromonas capillaris. (Described in SEQ ID NO: 3 of W ⁇ 01 / 88144).
- a desired site is introduced into a desired site using a site-directed mutagenesis method. Mutations in the gene sequence can be introduced.
- the method of site-specifically mutating the amino acid sequence of a gene can be performed using a recombinant DNA method, a PCR method, or the like. For example, if an appropriate restriction enzyme recognition sequence is present on both sides of the target site in the PHA synthase gene at which mutation is desired, a region containing the site desired to be mutated is cut with the restriction enzyme.
- the cassette After removal of the DNA fragments, the cassette can be subjected to a cassette mutation method in which a DNA fragment mutated only at the target site by chemical synthesis or the like is inserted.
- the site-specific mutation introduced by PCR is performed by introducing a mutation primer in which the desired mutation is introduced at the desired site in the PHA synthase gene where mutation is desired, and a mutation containing the sequence of the terminal site of the gene.
- One side of the gene is amplified with an amplification primer having no mutation, and a mutation primer having a sequence complementary to the mutation primer and the other end of the gene are amplified.
- the amplification can be performed by amplifying the other with an amplification primer having no mutation including the sequence of the site, annealing the two amplified fragments obtained, and then performing PCR with the two types of amplification primers. I can do it.
- the obtained site-specific construct is confirmed by determining the nucleotide sequence.
- the nucleotide sequence can be determined by a method known in the art using an automatic nucleotide sequencer or the like.
- any carbon source can be used without particular limitation as long as yeast can be used, such as glucose, oils and fatty acids.
- these carbon sources are metabolized via the ⁇ -oxidation pathway, but metabolic intermediates in the ⁇ -oxidation pathway efficiently synthesize polyester (T. Fukui, Y. Doi, J. Bacteriol., 179, No. 15, 4821—4830 (1997); Q. Ren et al., J. Bacteriol., 182, No. 10, 2978—2981 (2000)).
- / 3 in yeast is performed in peroxisomes, which are small organs in Itoda vesicles, enzymes involved in polyester synthesis must be localized in peroxisomes for efficient polyester synthesis. Is preferred.
- Proteins to be transported to peroxisomes are synthesized on free ribosomes, and transported to peroxisomes by the action of a peroxisome orientation signal in the protein sequence (S. Subramani, J. Membrane Biol. , 125, 99-106 (1992), Yasuyuki Itai, Biology and Biology, 35, No. 10, 687-695 (1997), EH Hettema, Biochim. Biophys. Acta, 1451, 17-34 (1999) ).
- DNA encoding these peroxisome orientation signals to a gene encoding an enzyme involved in the synthesis of polyester, that is, the above-mentioned PHA synthase mutant gene.
- an enzyme involved in the synthesis of the polyester that is, a PHA synthase mutant can be localized in peroxisomes, and the polyester can be synthesized efficiently.
- SKL seerine-lysine-single-mouth isine
- AKI alanine-lysine-isoleucine
- nucleotide sequence corresponding to the above amino acid there is no particular restriction on the nucleotide sequence corresponding to the above amino acid.
- the nucleotide sequence of SEQ ID NO: 4 can be used for SKL
- the nucleotide sequence of SEQ ID NO: 5 can be used for AKI.
- the nine amino acid sequences “(arginine / lysine) — (leucine Z valine Z isoleucine) — (5 amino acids) — (histidine / gunoletamine) — (leucine Zalanine)” present near the N-terminus are also peroxisome-oriented. Also known as a signal. Insertion and addition of these sequences to a PHA synthase mutant can also localize the enzyme to peroxisomes.
- the gene expression cassette of the present invention comprises the mutant gene of the above (2), a promoter and a terminator that function in yeast.
- a DNA sequence such as a promoter and an upstream activation region (UAS) is located at the upstream of the gene, and a poly-A is attached at the 3 ′ downstream of the gene.
- a DNA sequence such as an additional signal and a terminator is required. If there is an appropriate site on the yeast chromosome that satisfies the above conditions, the gene may be directly inserted, or the gene may be inserted into a plasmid having an appropriate promoter and terminator, and this plasmid may be inserted. Yeast can also be transformed.
- a gene expression cassette in which a promoter is linked to the 5 ′ upstream of the gene and a terminator is linked to the 3 ′ downstream, and this is transformed into yeast.
- the promoter and terminator any sequence can be used as long as it functions in yeast as a host. Promoters include those that express constitutively and those that express inductively, and any promoter may be used.
- the promoter and terminator when Candida maltosa is used as a host, the promoter and terminator preferably function in Candida maltosa, and the promoter and terminator are preferably Candida maltosa. Les, preferably from the origin. More preferably, a promoter derived from the ALK1, ALK2, and ALK5 genes of Candida maltosa, and a terminator derived from the ALK1 gene are used.
- promoter ALKlp WOOl / 88144
- ALK5 gene promoter ALK5p SEQ ID NO: 6
- a promoter Yamague et al., 2002 Abstracts of Japanese Society of Agricultural Chemistry, pl 91
- ARR alkane responsive nore region
- the base sequence of one of the above promoter and terminator is a base sequence in which one or more bases have been deleted, substituted and / or added, as long as the base sequence functions in Candida maltosa.
- the ⁇ base sequence in which one or more bases have been deleted, substituted and / or added '' refers to a protein nucleic acid enzyme extra gene amplification PCR method TAKKAJ 35 (17), 2951-3178 (1990) or Henry A. Erlich, edited by Ikuyuki Karoto, translated by PCR technology (1990) and other methods well known to those skilled in the art to delete, replace and / or add as many bases as possible. And / or means an added nucleotide sequence.
- the terminator is a DNA encoding a peroxisome orientation signal. It is linked to the 3 'downstream of the gene encoding the added PHA synthase mutant, respectively.
- the vector used for construction of the gene expression cassette may be any vector as long as it is a plasmid that autonomously propagates in Escherichia coli, and may also have a region that can autonomously propagate in yeast. Vectors capable of autonomous propagation in yeast are retained in the cells. Further, the gene expression cassette can be integrated on the chromosome.
- pUTUl capable of autonomous replication in Candida 'maltosa
- pUTUl capable of autonomous replication in Candida 'maltosa
- the method of linking the promoter and terminator with the structural gene to construct the gene expression cassette of the present invention is not particularly limited.
- a PCR method can also be used to create a restriction enzyme site.
- the method described in WO01 / 88144 can be used.
- yeasts which are not particularly restricted are deposited with depository institutions (eg, IFO, ATCC, etc.) of strains of the genus Acicloconidium, genus Ambrosiozyma, and genus Ambrosiozyma.
- depository institutions eg, IFO, ATCC, etc.
- Yeasts such as genus owia, genus Zygoascus, genus Zygosaccharomyces, genus Zygowilliopsis and genus Zygozyma can be used.
- the yeast used as a host of the transformant of the present invention is not particularly limited. Among them, Candida maltosa, which is preferably of the genus Candida or Yarrowia, is preferred. Candida 'maltosa, which is more preferred by Yarrowia lipolytica, is particularly preferred.
- Candida maltosa AC16 strain has an accession number.
- FERM BP-7366 was internationally deposited on November 15, 2000 at the National Institute of Advanced Industrial Science and Technology Patent Organism Depositary 1 at Tsukuba-Higashi 1-chome 1-Chuo No. 6 Ibaraki, Japan ing.
- the transformant of the present invention is obtained by introducing at least one gene expression cassette of the above (3) into yeast.
- a Candida maltosa CHA1 strain (S. Kawai, et al, Agric. Biol. Chem., Vol. 55, 59-65 (1991)) can be used as a host.
- the present strain is transformed with a plasmid vector or the like containing a gene expression cassette involved in polymer synthesis, and a Candida * having a plasmid such as pARR-ORF2S as shown in Examples described below *
- a maltosa transformant can be prepared.
- AC16 pUTA-149NSx2 which is a transformant into which plasmid pARR-149NSx2 has been introduced (Accession number: FERM BP-10019, original deposit date: May 8, 2003; international deposit based on the Budapest Treaty) Transferred to deposit), Plasmid pARR_149NS / 171DGx2 (Accession number FERM BP_10017, Deposit date: April 27, 2004, international deposit based on the Budapest Treaty),
- polyester is collected from a culture obtained by culturing the transformant of the present invention.
- the production of the polyester of the present invention can be carried out by adding the above transformant to a culture medium, culturing the resultant, and then recovering the polyester from the obtained cultured cells or culture.
- the culture temperature is a temperature at which the bacterium can grow, preferably 15 ° C to 40 ° C, more preferably 20 ° C to 40 ° C, and still more preferably 28 ° C to 34 ° C.
- the culture time is not particularly limited. For example, in batch culture, 117 days are preferable, and continuous culture is also possible.
- the culture medium is not particularly limited as long as yeast can be used.
- a medium containing a carbon source, a nitrogen source, inorganic salts, and other organic nutrient sources can be used.
- the carbon source is not particularly limited as long as it can be assimilated by yeast, and examples thereof include carbohydrates, fats and oils, fatty acids, and n-paraffin.
- carbohydrate include gnocose, sucrose, glycerin and the like.
- oils and fats include rapeseed oil, coconut oil, palm oil, palm kernel oil and the like.
- fatty acids include saturated 'unsaturated fatty acids such as hexanoic acid, octanoic acid, decanoic acid, lauric acid, oleic acid, palmitic acid, linoleic acid, linolenic acid, and myristic acid, and ester salts of these fatty acids.
- Fatty acid derivatives of Examples of n-paraffin include dodecane and tetradecane.
- an inducer for example, alcohol
- Inducers may be the primary carbon source.
- oil and fats can be used as the carbon source.
- yeasts that cannot assimilate oils and fats or that cannot efficiently assimilate Can be improved by adding lipase to the medium.
- lipase gene the ability to assimilate fats and oils can be imparted.
- nitrogen source examples include ammonium salts such as ammonia, ammonium chloride, ammonium sulfate, and ammonium phosphate, as well as peptone, meat extract, yeast extract, and the like.
- inorganic salts include, for example, potassium monophosphate , Potassium phosphate, magnesium phosphate, magnesium sulfate, sodium salt, and the like.
- organic nutrients include, for example, amino acids such as glycine, alanine, serine, threonine, and proline; vitamins such as vitamin B1, vitamin B12, biotin, nicotinamide, pantothenic acid, and vitamin C.
- amino acids such as glycine, alanine, serine, threonine, and proline
- vitamins such as vitamin B1, vitamin B12, biotin, nicotinamide, pantothenic acid, and vitamin C.
- the following method can be used to recover polyester from bacterial cells.
- the cells are separated from the culture using a centrifuge or the like, and the cells are washed with distilled water, methanol, and the like, and then dried.
- the polyester is extracted from the dried cells using an organic solvent such as black-mouthed form.
- Cell components are removed from the organic solvent solution containing the polyester by filtration or the like, and a poor solvent such as methanol or hexane is added to the filtrate to precipitate the polyester.
- the supernatant can be removed from the precipitated polyester by filtration or centrifugation, and the polyester can be recovered by drying.
- yeast is used as a cell producing polyester, the above simple separation and recovery method can be used.
- the obtained polyester is analyzed by, for example, gas chromatography, nuclear magnetic resonance, or the like.
- the GPC method can be used for measuring the molecular weight. After dissolving the recovered dried polymer with chlorophore, this solution can be analyzed using a Shimadzu GPC system equipped with Shodex K805L (manufactured by Showa Denko KK), and chromatoform as the mobile phase. .
- Shodex K805L manufactured by Showa Denko KK
- a commercially available standard polystyrene or the like can be used as the molecular weight standard sample.
- a gene encoding a PHA synthase mutant derived from Aaeromonas capillar with improved enzyme activity, or a PHA synthesis derived from Aeromonas capillar with improved enzyme activity is provided.
- a gene encoding a mutant enzyme and a DNA encoding a peroxisome orientation signal added to the gene encoding the mutant Using a gene expression cassette having a motor and a terminator, a recombinant strain of Candida maltosa is prepared, and a polyester can be efficiently synthesized by culturing the transformant.
- a copolymerized polyester P (copolymerized by copolymerizing 3-hydroxybutyric acid represented by the formula (1) and 3-hydroxyhexanoic acid represented by the formula (2) 3 HB-CO-3HH) can be produced favorably.
- 3-hydroxyalkanoic acids having biodegradability and excellent physical properties including 3-hydroxybutyric acid and 3-hydroxyhexanoic acid represented by the above formulas (1) and (2) It has become possible to efficiently produce a copolymerized polyester obtained by co-polymerizing yeast with yeast.
- Candida's maltosa is an enzyme that translates CTG codons into serine instead of leucine. My mother. For this reason, CTG was not assigned to leucine codons. Codons corresponding to each amino acid were selected preferentially for codons frequently used in Candida's maltosa. The usage frequency of codons was referred to Klaus Wolf's Nonconvendtional Yeast in Biotechnology (published by Springer). In this way, the PHA synthase gene ORF2 (SEQ ID NO: 3 of WO01Z88144) was designed, chemically synthesized, and then cloned into the vector pUCNT (described in WO94Z03613).
- the PHA synthase gene was cloned using SEQ ID NO: 8 and SEQ ID NO: 9 as PCR primers.
- PUCNT was amplified.
- Pfu polymerase from Stratagene was used for amplification.
- the PCR conditions were 1 cycle at 96 ° C, 1 minute at 60 ° C, and 11 minutes at 68 ° C, and this cycle was repeated 18 times.
- the plasmid was cleaved, E. coli JM109 strain was transformed, and a plasmid was obtained from the transformant.
- the nucleotide sequence was confirmed using the primers of SEQ ID NOs: 10 to 14.
- the nucleotide sequence was determined using a DNA Sequencer 310 Genetic Analyzer manufactured by PERKIN EL MER APPLIED BIOSYSTEMS. In this way, a PHA synthase mutant gene ORF2-149NS in which the gene mutation was introduced only at the target site was prepared.
- the PHA synthase mutant genes ORF2 and ORF2-149NS described in Example 1 were each provided with a Candida's maltosa-derived promoter at the 5 'upstream and a 3' downstream And a terminator.
- the promoter used was the promoter ARRp with an ARR sequence added upstream of the promoter of the Alk2 gene (GenBank X55881), and the terminator ALK1 t of the Alkl gene (GenBank D00481) of Candida maltosa at the 3 'downstream. was decided to be concatenated.
- ARRp is obtained by binding the EcoRI-Xhol linker to the Pstl site of the gene (SEQ ID NO: 15) provided by the University of Tokyo and the synthetic DNA shown in SEQ ID NO: 16 to the EcoT14I site, and Converted to a form that can be cut out.
- the vector pUALl (described in WO01Z88144) was cut with EcoRI, blunt-ended, and ligated to prepare pUAL2 from which the EcoRI cleavage site had been removed.
- pUAL2 was digested with Pvul / PvuII, and ligated to the Pvul / Smal site of pSTV28 (Takara Shuzo) to produce pSTALl.
- Fig. 1 shows a schematic diagram of the construction of pSTARR from pUALl and a schematic diagram of each plasmid.
- ORF2 and ORF2-149NS described in Example 1 were expressed in Candida 'maltosa and oriented to peroxinorme.
- Ser_Lys_Leu (SKL) amino acid at the carboxyl terminal was decided to use Ser_Lys_Leu (SKL) amino acid at the carboxyl terminal as a peroxisome orientation signal to be added.
- ORF2S and ORF2S-149NS were prepared using the ORF2 and ORF2-149NS cloned into pUCNT as type III and SEQ ID NOS: 17 and 18 as primers. These PHA synthase mutant genes were linked to the Ndel and Pstl sites of pSTARR to construct pSTARR-ORF2S and pSTARR_ORF2S149NS.
- pUTA-1 (described in WO01 / 88144) was used as a vector for finally ligating the PHA synthase mutant gene.
- pSTARR- ⁇ RF2S and pSTARR- ⁇ RF2S149NS an expression cassette was cut out with Xhol / Sall, and the Sail site of pUTA-1 was bound to construct pARR-ORF2S and pARR-149NS.
- FIG. 2 shows a scheme for preparing pARR-149NSx2 and the like from pSTARR and a simple diagram of each plasmid.
- Reagents used for culturing yeast were those sold by Wako Pure Chemical unless otherwise noted.
- Candida 'Maltosa AC16 strain (FERM BP-7366), which is an ADE1 gene-disrupted strain and is internationally deposited at the Patent Organism Depositary of the National Institute of Advanced Industrial Science and Technology, is used.
- Plasmids pARR- ⁇ RF2S, pARR-149NS, pARR- ⁇ RF2Sx2 and pARR-149NSx2 each containing a gene expression cassette were introduced.
- the constructed plasmid was introduced into the host by the electric pulse method.
- Gene transfer device is BTX ELECTRO CELL MANIPULATO R 600 was used.
- the cuvette used was BM6200 manufactured by BIO MEDICAL CORPORATION CO. LTD. Plasmid 1 / il was added to 100 / il of the competent cells, 100 ⁇ l of the prepared solution of the combi- tive cells / plasmid was taken, injected into a cuvette, and set in a pulse device. Subsequently, an electric pulse was applied under the conditions of a capacitance of 40 zF, a resistance of 246 ohm, and a voltage of 1.9 KV. After the pulsing, 1 ml of 1 M sorbitol was added to each cuvette, mixed gently, and left at room temperature for 1 hour.
- the transformant was cultured on a selection plate (0.67 w / v% yeast nitrogen base without amino acid (manufactured by Difco), 2 wz% knollose, 2 w / v% agar).
- a transformant into which the plasmid pARR_149NSx2 has been introduced has been internationally deposited at the Patent Organism Depositary of the National Institute of Advanced Industrial Science and Technology as AC16 pUTA_149NSx2 (FERM BP-10019).
- Candida maltosa transformant into which a gene required for polymer production was introduced was cultured as follows.
- the medium used was a YNB medium (0.6% w / v% yeast nitrogen base with sodium amino acid, 2% w / v glucose) as a pre-culture medium, an M2 medium (12.7 g / L ammonium sulfate, 1.
- the glycerol stock 500 of each transformant was inoculated into a 500 ml Sakaguchi flask containing 50 ml of a pre-culture medium, cultured for 20 hours, and placed in a 2 L Sakaguchi flask containing 300 mL of the production medium at 10 v / v. % Inoculated. This was cultured under the conditions of a culture temperature of 30 ° C., a shaking speed of 90 rpm, and culture for 2 days.
- the cells were collected from the culture solution by centrifugation, suspended in 80 ml of distilled water, crushed with an ultra-high pressure homogenizer (APV Rannie2000; 15000 Psi for 15 minutes), and then centrifuged to obtain a precipitate. After washing with methanol, freeze drying did.
- ADV Rannie2000 ultra-high pressure homogenizer
- the cells were removed by filtration, the filtrate was concentrated to 12 ml with an evaporator, and about 10 ml of hexane was added to the concentrate to precipitate a polymer.
- Table 1 shows the culture results.
- the measurement of the molecular weight was performed as follows. After 10 mg of the collected dry polymer was dissolved in 5 ml of chloroform, insolubles were removed by filtration. This solution was analyzed using a GPC system manufactured by Shimadzu Corporation equipped with Shodex K805L (300x8 mm, two-piece connection) (manufactured by Showa Denko KK), and a chromate form as a mobile phase.
- GPC system manufactured by Shimadzu Corporation equipped with Shodex K805L (300x8 mm, two-piece connection) (manufactured by Showa Denko KK), and a chromate form as a mobile phase.
- For the molecular weight standard sample commercially available standard polystyrene was used, and the
- the PHA of the present invention was compared to yeast transformed with plasmids pARR- ⁇ RF2S and pARR-ORF2Sx2 containing an expression set consisting of a gene encoding a wild-type PHA synthase.
- the yeast transformed with the plasmids pARR-149NS and pARR-149NSx2 containing the expression cassette comprising the mutant gene encoding the synthetase mutant the polymer content and 3HH fraction are improved, and the PHA synthase mutation of the present invention is improved.
- the molecular weight of the obtained PHA tended to increase not only by confirming the effect of improving body activity. Thus, the usefulness of the PHA synthase mutant of the present invention was confirmed.
- a mutant in which aspartic acid, which is the 171st amino acid of PHA synthase, was substituted with glycine was produced using the method described in Example 1.
- SEQ ID NO: 19 and SEQ ID NO: 20 were used as primers for introducing mutations.
- the 149th amino acid A double mutant in which Gin is replaced with serine and 171 amino acid aspartic acid is replaced with glycine is the same as in Example 1 except that the PHA synthase mutant gene ORF2-149NS prepared in Example 1 is type II. It was produced by the method described above.
- the PHA synthase mutant gene ORF2-171DG and the PHA synthase double mutant gene ⁇ RF2_149NS / 171DG were completed.
- ALKlt of pSTARR-ORF2S171DG and pSTARR-ORF2S149NS / 171DG was removed with Pstl / Sall, and a plasmid into which LAC4t amplified with the primers shown in SEQ ID NOS: 22 and 23 was introduced instead was prepared.
- the PHA synthase mutant expression cassette in which the terminator was replaced was excised with Xhol / Sall, respectively, and ligated to the Sail site of plasmids pARR-171DG and pARR-149NS / 171DG to obtain the PHA synthase mutant gene cassette.
- Plasmid pARR-171DGx2 and pARR-149NS / 171DGx2 Two transfected plasmids pARR-171DGx2 and pARR-149NS / 171DGx2 were completed.
- plasmid pARR_149NS / 171DGx2 (FERM BP-10017) has been internationally deposited at the Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology.
- These plasmids were introduced into Candida 'Maltosa AC16 strain (FERM BP-7366) by the method described in Example 3, polymer production and polymer analysis were performed by the method described in Example 4, and the results were tabulated. 2 and compared with the results of Example 4.
- the PHA synthase mutant of the present invention was compared to a yeast transformed with the plasmid pARR- ⁇ RF2Sx2 containing an expression set consisting of a gene encoding a wild-type PHA synthase.
- Plasmid containing an expression cassette consisting of a mutant gene coding for pARR-171DGx2 has an increased polymer content in yeast transformed with an expression cassette consisting of a double mutant gene encoding a PHA synthase double mutant.
- the yeast transformed with the plasmid containing pARR-149NS / l71DGx2 it was revealed that the polymer content was further improved and the 3HH fraction was improved.
- the usefulness of the PHA synthase mutant of the present invention was confirmed.
- 3-hydroxyalkanoic acids having biodegradability and excellent physical properties including 3-hydroxybutyric acid and 3-hydroxyhexanoic acid represented by the above formulas (1) and (2) It has become possible to efficiently produce a copolymerized polyester obtained by co-polymerizing yeast with yeast.
- FIG. 1 is a schematic diagram of a pSTARR produced from pUAL1 and a simple diagram of each plasmid in the example.
- FIG. 2 is a schematic diagram showing the preparation of pARR-149NSx2 and the like from pSTARR in the Examples, and a simple diagram of each plasmid.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Biological Depolymerization Polymers (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0409631-2A BRPI0409631A (pt) | 2003-05-15 | 2004-05-14 | transformante e processo para a produção de poliéster empregando-se o mesmo |
EP04733092A EP1626087A4 (en) | 2003-05-15 | 2004-05-14 | IMPROVED TRANSFORMANT AND METHOD FOR THE PREPARATION OF POLYESTER THEREWITH |
CA002523984A CA2523984A1 (en) | 2003-05-15 | 2004-05-14 | Improved transformant and process for producing polyester using the same |
US10/554,934 US20070087421A1 (en) | 2003-05-15 | 2004-05-14 | Transformant and process for producing polyester using the same |
JP2005506197A JPWO2004101796A1 (ja) | 2003-05-15 | 2004-05-14 | 改良された形質転換体およびそれを用いたポリエステルの製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-137492 | 2003-05-15 | ||
JP2003137492 | 2003-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004101796A1 true WO2004101796A1 (ja) | 2004-11-25 |
Family
ID=33447258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/006542 WO2004101796A1 (ja) | 2003-05-15 | 2004-05-14 | 改良された形質転換体およびそれを用いたポリエステルの製造方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070087421A1 (ja) |
EP (1) | EP1626087A4 (ja) |
JP (1) | JPWO2004101796A1 (ja) |
CN (1) | CN1791673A (ja) |
BR (1) | BRPI0409631A (ja) |
CA (1) | CA2523984A1 (ja) |
RU (1) | RU2005139128A (ja) |
TW (1) | TW200508388A (ja) |
WO (1) | WO2004101796A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1726637A4 (en) * | 2004-03-04 | 2007-09-26 | Kaneka Corp | NEW TRANSFORMER AND METHOD FOR THE PREPARATION OF POLYESTER USING THEREOF |
JP2008029218A (ja) * | 2006-07-26 | 2008-02-14 | Kaneka Corp | 酵素活性を低下させた微生物を用いる共重合ポリエステルの製造方法 |
JP5468779B2 (ja) * | 2006-07-21 | 2014-04-09 | 株式会社カネカ | 遺伝子置換微生物およびそれを用いたポリエステルの製造方法 |
JPWO2020218565A1 (ja) * | 2019-04-26 | 2021-09-27 | 株式会社 フューエンス | ポリヒドロキシアルカン酸及びその製造方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104845927A (zh) * | 2006-07-21 | 2015-08-19 | 株式会社钟化 | 基因取代微生物及使用该微生物的聚酯制造方法 |
US11186831B2 (en) * | 2018-01-16 | 2021-11-30 | Kaneka Corporation | Mutant polyhydroxyalkanoate synthase, gene thereof and transformant, and method for producing polyhydroxyalkanoate |
WO2020218566A1 (ja) | 2019-04-26 | 2020-10-29 | 株式会社フューエンス | 高分子量コポリマーを合成するための遺伝子 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003033707A1 (fr) * | 2001-10-10 | 2003-04-24 | Kaneka Corporation | Gene d'enzyme participant a la synthese de polyester et procede de production de polyester a l'aide dudit gene |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3168826D1 (en) * | 1980-11-18 | 1985-03-21 | Ici Plc | Polymer blends |
JP2777757B2 (ja) * | 1991-09-17 | 1998-07-23 | 鐘淵化学工業株式会社 | 共重合体およびその製造方法 |
JP3062459B2 (ja) * | 1996-08-14 | 2000-07-10 | 理化学研究所 | ポリエステル重合酵素遺伝子及びポリエステルの製造方法 |
EP1283266A4 (en) * | 2000-05-19 | 2005-01-05 | Kaneka Corp | TRANSFORMANT AND PROCESS FOR PRODUCING POLYESTER USING THE TRANSFORMANT |
ATE405640T1 (de) * | 2001-12-10 | 2008-09-15 | Riken | Verfahren zur herstellung von biologisch abbaubarem polyester |
-
2004
- 2004-05-14 JP JP2005506197A patent/JPWO2004101796A1/ja not_active Abandoned
- 2004-05-14 TW TW093113758A patent/TW200508388A/zh unknown
- 2004-05-14 CA CA002523984A patent/CA2523984A1/en not_active Abandoned
- 2004-05-14 WO PCT/JP2004/006542 patent/WO2004101796A1/ja active Application Filing
- 2004-05-14 CN CNA2004800133296A patent/CN1791673A/zh active Pending
- 2004-05-14 RU RU2005139128/13A patent/RU2005139128A/ru not_active Application Discontinuation
- 2004-05-14 BR BRPI0409631-2A patent/BRPI0409631A/pt not_active Application Discontinuation
- 2004-05-14 US US10/554,934 patent/US20070087421A1/en not_active Abandoned
- 2004-05-14 EP EP04733092A patent/EP1626087A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003033707A1 (fr) * | 2001-10-10 | 2003-04-24 | Kaneka Corporation | Gene d'enzyme participant a la synthese de polyester et procede de production de polyester a l'aide dudit gene |
Non-Patent Citations (2)
Title |
---|
KICHISE T. ET AL: "Enhanced accumulation and changed monomer composition in polyhydroxyalkanoate (PHA) copolyester by in vitro evolution of aeromonas caviae PHA synthase", APPL. ENVIRON. MICROBIOL., vol. 68, no. 5, 2002, pages 2411 - 2419, XP002961039 * |
See also references of EP1626087A4 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1726637A4 (en) * | 2004-03-04 | 2007-09-26 | Kaneka Corp | NEW TRANSFORMER AND METHOD FOR THE PREPARATION OF POLYESTER USING THEREOF |
JP5468779B2 (ja) * | 2006-07-21 | 2014-04-09 | 株式会社カネカ | 遺伝子置換微生物およびそれを用いたポリエステルの製造方法 |
JP2008029218A (ja) * | 2006-07-26 | 2008-02-14 | Kaneka Corp | 酵素活性を低下させた微生物を用いる共重合ポリエステルの製造方法 |
JPWO2020218565A1 (ja) * | 2019-04-26 | 2021-09-27 | 株式会社 フューエンス | ポリヒドロキシアルカン酸及びその製造方法 |
JP7063513B2 (ja) | 2019-04-26 | 2022-05-09 | 株式会社 フューエンス | ポリヒドロキシアルカン酸及びその製造方法 |
JP2022093402A (ja) * | 2019-04-26 | 2022-06-23 | 株式会社 フューエンス | ポリヒドロキシアルカン酸及びその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
RU2005139128A (ru) | 2006-05-27 |
CA2523984A1 (en) | 2004-11-25 |
TW200508388A (en) | 2005-03-01 |
US20070087421A1 (en) | 2007-04-19 |
CN1791673A (zh) | 2006-06-21 |
EP1626087A1 (en) | 2006-02-15 |
BRPI0409631A (pt) | 2006-04-25 |
JPWO2004101796A1 (ja) | 2006-07-13 |
EP1626087A4 (en) | 2006-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2758138C2 (ru) | Рекомбинантные клетки дрожжей, продуцирующие полимолочную кислоту, и их использования | |
WO2018021046A1 (ja) | 3hh単位含有共重合phaを生産する形質転換体、及び当該phaの製造方法 | |
JP7360329B2 (ja) | 変異型ポリヒドロキシアルカン酸合成酵素、その遺伝子および形質転換体、並びに、ポリヒドロキシアルカン酸の製造方法 | |
Chae et al. | Biosynthesis of poly (2-hydroxybutyrate-co-lactate) in metabolically engineered Escherichia coli | |
JP6313708B2 (ja) | 高分子量pha生産微生物とそれを用いた高分子量phaの製造方法 | |
US7083972B2 (en) | Transformant and process for producing polyester by using the same | |
WO2004101796A1 (ja) | 改良された形質転換体およびそれを用いたポリエステルの製造方法 | |
KR102693462B1 (ko) | 5-하이드록시발레르산 생산용 재조합 코리네박테리움 글루타미쿰 균주 및 이를 이용한 5-하이드록시발레르산 생산방법 | |
JP7535527B2 (ja) | 形質転換微生物、及び当該微生物を用いたポリヒドロキシアルカン酸の製造方法 | |
JP2008086238A (ja) | ポリヒドロキシアルカノエートの製造方法 | |
JPWO2005085415A1 (ja) | 新規形質転換体およびそれを用いたポリエステルの製造方法 | |
JP2024091851A (ja) | 形質転換微生物、及びポリヒドロキシアルカン酸の製造方法 | |
JPWO2005098001A1 (ja) | 新規形質転換体 | |
US7429469B2 (en) | Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same | |
CA2931591C (en) | Fumarate reductases | |
JPWO2008090873A1 (ja) | ポリヒドロキシアルカノエートの製造方法 | |
JPWO2017104722A1 (ja) | スクロース資化性を有するpha生産微生物、及び該微生物を用いたphaの製造方法 | |
JP2021108581A (ja) | 形質転換微生物、及びポリヒドロキシアルカン酸の製造方法 | |
JP7425783B2 (ja) | 形質転換微生物、及びポリヒドロキシアルカン酸の製造方法 | |
WO2024166829A1 (ja) | 形質転換微生物、及びポリヒドロキシアルカン酸の製造方法 | |
WO2024166830A1 (ja) | 形質転換微生物、及びポリヒドロキシアルカン酸の製造方法 | |
CN114026247A (zh) | 用于合成高分子量共聚物的基因 | |
CN104845927A (zh) | 基因取代微生物及使用该微生物的聚酯制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005506197 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2523984 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2217/KOLNP/2005 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048133296 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004733092 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005139128 Country of ref document: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004733092 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0409631 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007087421 Country of ref document: US Ref document number: 10554934 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10554934 Country of ref document: US |